HQL: Still Offers Attractive Value As Long As Interest Rates Decline

abrdn Life Sciences Investors remains a buy for high-yield seekers, offering a 10.1% dividend yield and diversified healthcare exposure. HQL trades at a 7.92% discount to NAV, with its share price historically benefiting from lower interest rates and sector growth initiatives. The fund's focus on income, option writing, and heavy biotech allocation limits long-term capital appreciation and has led to underperformance versus peers like THQ and THW.

Seeking Alpha • Nov 6, 2025

HQL: We Should Be Accumulating During The Weakness

HQL offers a high 12% yield and trades at a discount, making it attractive for income-focused investors seeking healthcare sector exposure. The fund is heavily weighted in biotechnology, leading to underperformance versus broader healthcare ETFs and higher sensitivity to sector weakness. Dividend coverage remains consistent despite recent earnings volatility, but distributions are not tax-efficient and rely on capital gains.

Seeking Alpha • Aug 21, 2025

CEF Insights: The Future Of Healthcare Investing

Groundbreaking AI-powered initiatives are set to transform the healthcare landscape, potentially revolutionizing cancer research and healthcare investing. Aberdeen Investments' four healthcare-focused closed-end funds meet various investor needs: THQ/THW for income and stability, HQH/HQL for growth and innovation exposure. Jason Akus, Portfolio Manager and Head of Healthcare Investments with Aberdeen Investments, gives insight into how new innovations may impact investment opportunities.

Seeking Alpha • Jun 25, 2025

HQL: Positive Outlook Due To Increased Healthcare Spending

I maintain my buy rating on HQL due to its attractive 14% yield, discounted valuation, and long-term healthcare growth outlook. Despite recent NAV declines and inconsistent income, HQL's performance is tied to macro conditions, not internal flaws, and should improve as the sector rebounds. HQL's diversified biotech-heavy portfolio, lack of leverage, and simple strategy offer stability and upside as healthcare spending rises.

Seeking Alpha • Jun 4, 2025

These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount

My definition of a high yield is any yield at least twice the level of the S&P 500's yield. The threshold is currently around 2.56%.

The Motley Fool • Apr 30, 2025

5 Best CEFs This Month For Yields Up To 14%

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

Seeking Alpha • Mar 23, 2025

HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X

HQL: Attractive Valuation, Aligned To Benefit From Aging Gen X

Seeking Alpha • Feb 11, 2025

Aberdeen Or 'abrdn' - Either Way The Coverage Looks A Bit Thin

Closed-end funds offer unique advantages, like buying at discounts and leveraging with institutionally priced debt, making them ideal income-generating vehicles. Cash distributions are key contributors to total return, but it is essential to be sure they are actually covered by fund earnings. Some investors overly prioritize distribution yields, neglecting the importance of considering total return as a whole.

Seeking Alpha • Jan 17, 2025

5 Best CEFs This Month For 8.5% Yield (November 2024)

For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

Seeking Alpha • Nov 24, 2024

5 Best CEFs This Month For 9.5% Yield (October 2024)

For income investors, closed-end funds, or CEFs, remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. CEFs are generally characterized by higher volatility and deeper draw-downs than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer “excess” discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.

Seeking Alpha • Oct 27, 2024